Xencor, Inc.

XNCRNASDAQ • USD
ThemeHealthcare - Oncology›Immunotherapy & Immuno-Oncology
29.18 USD
↗ 4.00 (15.89%)AT CLOSE (03:59 PM EDT)
29.28
↗ 0.09 (0.33%)
POST MARKET (AS OF 07:58 PM EDT)
Post Market
AS OF 07:58 PM EDT
29.28
↗ 0.09 (0.33%)
🔴Market: CLOSED

Shares of Xencor, Inc. (XNCR) are trading at $29.17. Our models show a "Strong Buy" technical signal alongside a "Neutral" fundamental rating. Notable factors include a robust Altman Z-Score, negative Return on Equity and a bullish Golden Cross on the moving averages. Valuation-wise, the stock is priced at a premium — multiples like P/E and EV/EBITDA sit above sector averages.

Technical & fundamental data as of Oct 26, 2026.

Open?$32.31
High?$33.60
Low?$28.84
Prev. Close?$25.18
Volume?8.9M
Avg. Volume?1.5M
VWAP?$31.25
Rel. Volume?6.12x
Bid / Ask
Bid?$24.88 × 100
Ask?$33.14 × 100
Spread?$8.26
Midpoint?$29.01
Valuation & Ratios
Market Cap?1.9B
Shares Out?74.4M
Float?72.3M
Float %?97.2%
P/E Ratio?N/A
P/B Ratio?3.72
EPS?-$2.20
Dividend?0.00%
Ex-Dividend?N/A
News
Profile
Xencor Inc is a clinical-stage biopharmaceutical company focused on discovering and developing engineered antibody therapeutics to treat patients with cancer and autoimmune diseases. The company uses its XmAb technology platform to create antibody product candidates. Its pipeline includes XmAb819, XmAb541, XmAb808, XmAb942, Plamotamab and XmAb657. The group earns its revenue from collaboration agreements and licensing agreements and operates as a single reportable segment focused on discovering and developing engineered antibody therapeutics to treat patients with cancer and autoimmune diseases who have unmet medical needs.
Themes
Healthcare - Oncology›Immunotherapy & Immuno-OncologyBiotech - Drug Development›Immunology & Autoimmune
Employees
260
Market Cap
1.9B
Industry
PHARMACEUTICAL PREPARATIONS
Website
www.xencor.com
Listed
2013-12-03
Address
465 N. HALSTEAD ST.
PASADENA, CA 91107
Phone: 626-305-5900
Technical OutlookStrong Buy
Strong SellNeutralStrong Buy
Long-Term (Tide)?▲ Bullish(+3/3)
Medium-Term (Wave)?▲ Bullish(+2/3)
Short-Term (Ripple)?▲ Bullish(+2/3)
MA Alignment?Mixed
Full Technical Analysis →
Fundamental OutlookNeutral
Strong SellNeutralStrong Buy
F-Score?
40
Z-Score?
75
Momentum?
57
Short Sent.?
35
Piotroski F-Score?4/9Mixed
Altman Z-Score?3.13Safe
Confidence?66%Moderate
Full Fundamental Analysis →
Short InterestHigh
Short % of Float?16.98%High
Short Interest?12.3M
Days to Cover?9.1
Free Float72.3M
Avg Daily Volume1.3M
Settlement Date2026-10-15
Financial Health
Current Ratio?6.39Strong
Quick Ratio?6.39Strong
Cash Ratio?0.55Adequate
Debt/Equity?0.21Low
ValuationFAIRLY VALUEDvs 1 peers + S&P 500
Score
58/100
P/E?
N/A▾
P/B?
Peers
100
S&P
47
3.72FAIR▾
P/S?
Peers
100
S&P
3
17.84HIGH▾
P/FCF?
N/A▾
EV/EBITDA?
S&P
97
-9.4CHEAP▾
EV/Sales?
Peers
100
S&P
3
18.41HIGH▾
Returns & Efficiency
ROE?
S&P
6
-32.5%WEAK▾
ROA?
S&P
3
-22.5%WEAK▾
Cash Flow & Enterprise
FCF?$-208285000
Enterprise Value?$1.9B
Fundamentals ratios updated end of day
MarketsMoversWatchlist